BBOT Stock Price Chart
BBOT Earnings
BridgeBio Oncology Therapeutics Inc
$8.08
-0.61%
$-0.05
At close: May 13, 16:00:00 GMT-4
$8.08
0%
$0
Pre-market: May 14, 07:03:02 GMT-4
Back
BridgeBio Oncology Therapeutics Inc (BBOT) Earnings
Key Stats
Prev.Close
$8.13
Open
$7.99
Day's Range
$7.6 - $8.1
52 week range
$8 - $14.87
Volume
274.4K
Avg.Volume
317.3K
Dividend yield
--
EPS (TTM)
0.20
Market Cap
$646.6M
What is BBOT?
Helix Acquisition Corp. II operates as a blank check company. The company is headquartered in Boston, Massachusetts. The company went IPO on 2024-02-09. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company has entered into a business combination agreement with TheRas, Inc., doing business as BridgeBio Oncology Therapeutics. Upon closing of the transaction, the combined company will be renamed BridgeBio Oncology Therapeutics, Inc.
